Indicadores de riesgo de morbilidad prevenible causada por medicamentos

Dago Martínez, Ana; Arcos González, Pedro; Álvarez de Toledo Saavedra, Flor; Baena Parejo, María Isabel; Martínez Olmos, José; Íñigo Gorostiza Ormaetxe, Íñigo.
Gac. sanit. (Barc., Ed. impr.) ; 21(1): 29-36, ene. 2007. tab
Artículo en Es | IBECS (España) | ID: ibc-053931

Documentos relacionados

  1. Shortening Synthetic Routes to Small Molecule Active Pharmaceutical Ingredients Employing Biocatalytic Methods.
  2. Biocatalysis: An Eco-Friendly Scenario for the Manufacturing of APIs.
  3. Eosinophil Knockout Humans: Uncovering the Role of Eosinophils Through Eosinophil-Directed Biological Therapies.
  4. The role of community pharmacy in wound care: a scoping review.
  5. Predicting drug characteristics using biomedical text embedding.
  6. A review on biomass-derived levulinic acid for application in drug synthesis.
  7. Ionic Liquids: New Forms of Active Pharmaceutical Ingredients with Unique, Tunable Properties.
  8. On the relationship between inhibition and receptor occupancy by nondepolarizing neuromuscular blocking drugs.
  9. Transformational strategies for optimizing use of medications and related therapies through us pharmacists and pharmacies: Findings from a national study.
  10. Unlocking the secrets of doxepin hydrochloride's crystal structure: Insights from high-quality powder diffraction analysis.